Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Atypical antipsychotics and diabetic ketoacidosis: a review.

Guenette MD, Hahn M, Cohn TA, Teo C, Remington GJ.

Psychopharmacology (Berl). 2013 Mar;226(1):1-12. doi: 10.1007/s00213-013-2982-3. Review.

PMID:
23344556
3.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
4.
5.

Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.

Polcwiartek C, Vang T, Bruhn CH, Hashemi N, Rosenzweig M, Nielsen J.

Psychopharmacology (Berl). 2016 Oct;233(21-22):3663-3672. Review.

PMID:
27592232
6.

Hyperglycemia and antipsychotic medications.

Haupt DW, Newcomer JW.

J Clin Psychiatry. 2001;62 Suppl 27:15-26; discussion 40-1. Review.

7.

Atypical antipsychotics and glucose homeostasis.

Bergman RN, Ader M.

J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.

PMID:
15816794
8.

Diabetic ketoacidosis among patients receiving clozapine: a case series and review of socio-demographic risk factors.

Nihalani ND, Tu X, Lamberti JS, Olson D, Olivares T, Costea GO, Tang W.

Ann Clin Psychiatry. 2007 Apr-Jun;19(2):105-12. Review. Erratum in: Ann Clin Psychiatry. 2007 Oct-Dec;19(4):329. Tu, Xin [added].

PMID:
17612850
9.

Metabolic consequences of antipsychotic therapy: preclinical and clinical perspectives on diabetes, diabetic ketoacidosis, and obesity.

Heal DJ, Gosden J, Jackson HC, Cheetham SC, Smith SL.

Handb Exp Pharmacol. 2012;(212):135-64. doi: 10.1007/978-3-642-25761-2_6. Review.

PMID:
23129331
10.

Atypical antipsychotics and glucose dysregulation: a systematic review.

Jin H, Meyer JM, Jeste DV.

Schizophr Res. 2004 Dec 1;71(2-3):195-212. Review.

PMID:
15474892
11.

[Diabetes mellitus associated with atypical antipsychotic medications: case report and review of the literature].

Reis JS, Alvarenga T, Rosário PW, Menezes PA, Rocha Rdos S, Purisch S.

Arq Bras Endocrinol Metabol. 2007 Apr;51(3):488-93. Review. Portuguese.

12.

Sertindole for schizophrenia.

Lewis R, Bagnall AM, Leitner M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001715. Review.

PMID:
16034864
13.

New onset diabetes and atypical antipsychotics.

Liebzeit KA, Markowitz JS, Caley CF.

Eur Neuropsychopharmacol. 2001 Feb;11(1):25-32. Review.

PMID:
11226809
14.

Atypical antipsychotics and weight gain.

[No authors listed]

Postgrad Med. 2003 Dec;114(6 Suppl Managing Metabolic):46-58. doi: 10.3810/pgm.12.2003.suppl31.180. Review.

PMID:
19667655
15.

Metabolic side effects of atypical antipsychotics in children: a literature review.

Fedorowicz VJ, Fombonne E.

J Psychopharmacol. 2005 Sep;19(5):533-50. Review.

PMID:
16166191
16.

Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

Henderson DC.

CNS Drugs. 2002;16(2):77-89. Review.

PMID:
11825099
17.

A review of the effect of atypical antipsychotics on weight.

Nasrallah H.

Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:83-96. Review.

PMID:
12504074
18.

Management of atypical antipsychotic drug-induced weight gain: focus on metformin.

Miller LJ.

Pharmacotherapy. 2009 Jun;29(6):725-35. doi: 10.1592/phco.29.6.725. Review.

PMID:
19476423
19.

Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.

Henderson DC.

Curr Diab Rep. 2002 Apr;2(2):135-40. Review.

PMID:
12643133
20.

The implications of weight changes with antipsychotic treatment.

Sussman N.

J Clin Psychopharmacol. 2003 Jun;23(3 Suppl 1):S21-6. Review.

PMID:
12832946
Items per page

Supplemental Content

Support Center